DOUGLASS B. GIVEN is an investment partner at Bay City Capital and has been with the firm since October 2000. He was formerly chief executive officer and a director of NeoRx, corporate senior vice president and chief technology officer of Mallinckrodt and chief executive officer and a director of Progenitor and Mercator Genetics. He also held positions as vice president at Schering-Plough Research Institute, vice president at Monsanto/G.D. Searle Research Laboratories and medical advisor at Lilly Research Laboratories. Dr. Given is the chairman of VIA Pharmaceuticals Board of Directors, chairman of Vivaldi Biosciences and a member of the SemBioSys Genetics Board of Directors. He is co-chairman of the Visiting Committee to the Division of Biological Sciences and the Pritzker School of Medicine at the University of Chicago. Dr. Given earned a doctor of medicine with honors and a doctor of philosophy from the University of Chicago and a master of business administration from the Wharton School of the University of Pennsylvania. He was a fellow in internal medicine and infectious diseases at Harvard Medical School and Massachusetts General Hospital.
| 
